KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
26.70
+7.46 (38.77%)
Apr 29, 2026, 12:08 PM EDT - Market open
KalVista Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2025 | FY 2024 | FY 2024 | FY 2023 | 2022 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Apr '25 Apr 30, 2025 | Dec '24 Dec 31, 2024 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | 2022 - 2018 |
| Cash & Equivalents | 229.34 | 131.62 | - | 31.79 | 56.24 | Upgrade
|
| Short-Term Investments | 70.87 | 89 | - | 178.61 | 93.14 | Upgrade
|
| Cash & Short-Term Investments | 300.21 | 220.62 | - | 210.4 | 149.38 | Upgrade
|
| Cash Growth | 36.08% | - | - | 40.85% | -10.12% | Upgrade
|
| Accounts Receivable | 2.59 | 11 | - | - | - | Upgrade
|
| Other Receivables | 8.71 | 4.14 | - | 10.87 | 18.64 | Upgrade
|
| Receivables | 11.3 | 15.14 | - | 10.87 | 18.64 | Upgrade
|
| Inventory | 3.43 | - | - | - | - | Upgrade
|
| Prepaid Expenses | 5.2 | 5.93 | - | 4.42 | 4.31 | Upgrade
|
| Total Current Assets | 320.15 | 241.69 | - | 225.69 | 172.33 | Upgrade
|
| Property, Plant & Equipment | 12.86 | 7.53 | - | 9.15 | 10.77 | Upgrade
|
| Other Long-Term Assets | 2.37 | 1.55 | - | 0.57 | 0.11 | Upgrade
|
| Total Assets | 335.38 | 250.77 | - | 235.4 | 183.2 | Upgrade
|
| Accounts Payable | 8.27 | 4.88 | - | 9.11 | 4.82 | Upgrade
|
| Accrued Expenses | 27.06 | 26.5 | - | 12.15 | 9.13 | Upgrade
|
| Current Portion of Long-Term Debt | 13.57 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 1.62 | 1.98 | - | 1.3 | 1.09 | Upgrade
|
| Current Unearned Revenue | - | 11 | - | - | - | Upgrade
|
| Other Current Liabilities | 6.84 | 0.81 | - | 0.25 | - | Upgrade
|
| Total Current Liabilities | 57.36 | 45.17 | - | 22.81 | 15.03 | Upgrade
|
| Long-Term Debt | 258.29 | 105.88 | - | - | - | Upgrade
|
| Long-Term Leases | 10.73 | 4.33 | - | 6.02 | 7.15 | Upgrade
|
| Long-Term Unearned Revenue | 11.71 | - | - | - | - | Upgrade
|
| Total Liabilities | 338.09 | 155.38 | - | 28.82 | 22.18 | Upgrade
|
| Common Stock | 0.05 | 0.05 | - | 0.04 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 767.06 | 753.73 | - | 679.75 | 507.13 | Upgrade
|
| Retained Earnings | -762.69 | -653.17 | - | -469.73 | -343.08 | Upgrade
|
| Comprehensive Income & Other | -7.13 | -5.21 | - | -3.49 | -3.06 | Upgrade
|
| Shareholders' Equity | -2.71 | 95.39 | - | 206.58 | 161.03 | Upgrade
|
| Total Liabilities & Equity | 335.38 | 250.77 | - | 235.4 | 183.2 | Upgrade
|
| Total Debt | 284.21 | 112.19 | - | 7.32 | 8.23 | Upgrade
|
| Net Cash (Debt) | 16.01 | 108.43 | - | 203.08 | 141.14 | Upgrade
|
| Net Cash Growth | -85.24% | - | - | 43.89% | -10.68% | Upgrade
|
| Net Cash Per Share | 0.30 | 2.18 | - | 5.52 | 5.06 | Upgrade
|
| Filing Date Shares Outstanding | 51.22 | 49.95 | 59.34 | 42.74 | 34.23 | Upgrade
|
| Total Common Shares Outstanding | 50.9 | 49.76 | 59.34 | 42.52 | 34.17 | Upgrade
|
| Working Capital | 262.79 | 196.52 | - | 202.88 | 157.29 | Upgrade
|
| Book Value Per Share | -0.05 | 1.92 | - | 4.86 | 4.71 | Upgrade
|
| Tangible Book Value | -2.71 | 95.39 | - | 206.58 | 161.03 | Upgrade
|
| Tangible Book Value Per Share | -0.05 | 1.92 | - | 4.86 | 4.71 | Upgrade
|
| Machinery | 4.51 | 3.23 | - | 2.81 | 3.05 | Upgrade
|
| Leasehold Improvements | 3.45 | 3.09 | - | 2.86 | 2.86 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.